Insider · CIK 0001493215
Rtw Investments, LP
directorownerother
Files at RCKT (ROCKET PHARMACEUTICALS, INC.), OBIO (Orchestra BioMed Holdings, Inc.), ALUR (ALLURION TECHNOLOGIES, INC.). First filing Apr 29, 2025, latest May 1, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$276k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OBIO: Orchestra BioMed Holdings, Inc.
OBIOOct 9, 2026 · close 5.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $149k 49,900 shares | +1% | +17% from low-53% from high | |
| 31Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $127k 50,000 shares | +1% | 0% from low-60% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Common Stock, $0.0001 par value per shareindirect: See footnotes | +991,544 | $1.67 | $1.7M | 3,138,798 | Nov 13, 2025 |
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Common Stock, $0.0001 par value per shareindirect: See footnotes | +767,848 | $1.67 | $1.3M | 2,427,089 | Nov 13, 2025 |
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Common Stock, $0.0001 par value per shareindirect: See footnotes | +96,896 | $1.67 | $162k | 298,992 | Nov 13, 2025 |
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Warrant (Right to Buy)derivativeindirect: See footnotes | +991,544 | - | - | 991,544 | Nov 13, 2025 |
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Warrant (Right to Buy)derivativeindirect: See footnotes | +767,848 | - | - | 767,848 | Nov 13, 2025 |
| Nov 12, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Warrant (Right to Buy)derivativeindirect: See footnotes | +96,896 | - | - | 96,896 | Nov 13, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: See footnotes | +822,722 | $3.35 | $2.8M | 2,147,254 | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: See footnotes | +631,954 | $3.35 | $2.1M | 1,659,241 | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: See footnotes | +37,863 | $3.35 | $127k | 202,096 | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Convertible Notederivativeindirect: See Footnotes | - | $2,756,117.00 | - | - | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Convertible Notederivativeindirect: See Footnotes | - | $2,756,117.00 | - | - | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Convertible Notederivativeindirect: See footnotes | - | $2,117,044.00 | - | - | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Convertible Notederivativeindirect: See footnotes | - | $2,117,044.00 | - | 0 | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Convertible Notederivativeindirect: See footnotes | - | $126,839.00 | - | - | Nov 7, 2025 |
| Nov 5, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Convertible Notederivativeindirect: See footnotes | - | $126,839.00 | - | - | Nov 7, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Common Stockindirect: See footnote | +1,000,000 | $40.03 | $40M | 19,188,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | JOther Common Stockindirect: See footnote | -1,000,000 | $3.11 | $3.1M | 18,188,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Common Stockindirect: See footnote | +41,000 | $19.09 | $783k | 18,229,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | JOther Common Stockindirect: See footnote | -41,000 | $3.11 | $127k | 18,188,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Common Stockindirect: See footnote | +59,000 | $17.81 | $1.1M | 18,247,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | JOther Common Stockindirect: See footnote | -59,000 | $3.11 | $183k | 18,188,457 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See footnote | -1 | - | - | 0 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See footnote | -1 | - | - | 0 | Sep 23, 2025 |
| Sep 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See footnote | -1 | - | - | 0 | Sep 23, 2025 |
| Aug 4, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Pre-Funded Warrants (Right to Buy)derivativeindirect: See footnote | +3,636,363 | $2.75 | $10.0M | 3,636,363 | Aug 6, 2025 |
| Apr 30, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stockindirect: Please see footnote | +49,900 | $2.99 | $149k | 8,306,063 | May 1, 2025 |
| Apr 29, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stockindirect: Please see footnote | +50,000 | $2.53 | $127k | 8,256,163 | Apr 29, 2025 |
| Apr 16, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: Please see footnotes | +822,722 | $3.35 | $2.8M | 1,324,532 | Apr 17, 2025 |
| Apr 16, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: Please see footnotes | +631,954 | $3.35 | $2.1M | 1,027,287 | Apr 17, 2025 |
| Apr 16, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Common Stock, $0.0001 par value per shareindirect: Please see footnotes | +37,863 | $3.35 | $127k | 164,233 | Apr 17, 2025 |
| Apr 16, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | AGrant or award Convertible Notederivativeindirect: Please see footnotes | - | $5,000,000.00 | - | - | Apr 17, 2025 |
| Apr 16, 2025 | ALUR ALLURION TECHNOLOGIES, INC. | CConversion Convertible Notederivativeindirect: Please see footnotes | - | $5,000,000.00 | - | - | Apr 17, 2025 |
| Dec 12, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Pre-funded Warrant (right to buy)derivativeindirect: See footnote | +400,000 | $12.49 | $5.0M | 3,526,955 | Dec 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.